B. Handen

发表

Guanfacine in Children with Autism and/or Intellectual Disabilities

A. Hardan, B. Handen, R. Sahl, 2008, Journal of developmental and behavioral pediatrics : JDBP.

Eating Habits and Dietary Status in Young Children with Autism

Cynthia R. Johnson, B. Handen, K. Sacco, 2008 .

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology

A. Fagan, H. D. Rosas, A. Brickman, 2020, Alzheimer's & dementia.

Practitioner review: Psychopharmacology in children and adolescents with mental retardation.

B. Handen, Richard Gilchrist, 2006, Journal of child psychology and psychiatry, and allied disciplines.

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen

Sterling C. Johnson, Matthew D. Zammit, C. Laymon, 2020, Alzheimer's & dementia.

Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

Sterling C. Johnson, Regina M. Hardison, W. Klunk, 2014, Brain : a journal of neurology.

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application

Sterling C. Johnson, Ciprian M. Crainiceanu, John Muschelli, 2020, IPMU.

Reactions to “Ethical challenges and complexities of including people with intellectual disability as participants in research” by Dr Teresa Iacono

B. Handen, M. Aman, 2006 .

Joint‐label fusion brain atlases for dementia research in Down syndrome

D. Minhas, A. Fagan, N. Tustison, 2022, Alzheimer's & dementia.

Validation of a Competency-Based Training Program in Developmental Disabilities

B. Handen, B. Sulzer-Azaroff, Thomas W. Zane, 1982 .

Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down’s syndrome

Young T. Hong, W. Klunk, P. Nestor, 2022, Neurobiology of Aging.

Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition

W. Klunk, E. McDade, C. Mathis, 2018, Alzheimer's & Dementia.

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population

Sterling C. Johnson, Bradley T. Christian, William E. Klunk, 2017, Alzheimer's & dementia.

Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome

Sterling C. Johnson, Matthew D. Zammit, W. Klunk, 2020, Neurobiology of Aging.

Amyloid accumulation in Down syndrome measured with amyloid load

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2020, Alzheimer's & dementia.

Integrating Biomarker Outcomes into Clinical Trials for Alzheimer’s Disease in Down Syndrome

M. Rafii, B. Handen, S. Zaman, 2019, The Journal of Prevention of Alzheimer's Disease.

Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.

Sterling C. Johnson, Patrick J. Lao, W. Klunk, 2017, Journal of Alzheimer's disease : JAD.

The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11–labeled Pittsburgh compound B

Sterling C. Johnson, Regina M. Hardison, Patrick J. Lao, 2016, Alzheimer's & Dementia.

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome

Matthew D. Zammit, C. Laymon, W. Klunk, 2020, Alzheimer's & dementia.

Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome

Regina M. Hardison, Patrick J. Lao, W. Klunk, 2017, Neurobiology of Aging.

Adverse side effects of methylphenidate among mentally retarded children with ADHD.

H. Feldman, B. Handen, A. Gosling, 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.

Tristram H. Smith, J. Hellings, X. Pan, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study

H. D. Rosas, B. Tycko, W. Klunk, 2020, Alzheimer's & dementia.

Physical Activity and Physical and Mental Health in Middle-Aged Adults with Down Syndrome.

O. Okonkwo, D. Plante, D. Tudorascu, 2022, Journal of policy and practice in intellectual disabilities.

Prediction of response to methylphenidate among children with ADHD and mental retardation.

H. Feldman, J. Janosky, B. Handen, 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

Usability and reliability of a remotely administered adult autism assessment, the autism diagnostic observation schedule (ADOS) module 4.

B. Parmanto, Andi Saptono, J. McGonigle, 2015, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.

H. Feldman, B. Handen, D. Ploof, 1990, Pediatrics.

A review of atomoxetine effects in young people with developmental disabilities.

Tristram H. Smith, X. Pan, L. E. Arnold, 2014, Research in developmental disabilities.

Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, R. Andridge, L. E. Arnold, 2017, Journal of child and adolescent psychopharmacology.

Classroom behavior and children with mental retardation: Comparison of children with and without ADHD

H. Feldman, J. Janosky, B. Handen, 1994, Journal of abnormal child psychology.

Parent Training for Disruptive Behavior

Tristram H. Smith, L. Scahill, E. Butter, 2018, Oxford Clinical Psychology.

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group

R. Litovsky, M. Rafii, J. Fortea, 2022, Journal of neurodevelopmental disorders.

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

H. D. Rosas, C. Laymon, W. Klunk, 2022, JAMA neurology.

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome

Young T. Hong, C. Laymon, W. Klunk, 2022, Neurobiology of Aging.

Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.

B. Tycko, W. Klunk, B. Ances, 2020, Journal of Alzheimer's disease : JAD.

Physical activity, memory function, and hippocampal volume in adults with Down syndrome

Jamie C. Peven, C. Laymon, O. Okonkwo, 2022, Frontiers in Integrative Neuroscience.

Comparison of longitudinal A β in non-demented elderly and Down syndrome

Patrick J. Lao, D. Minhas, J. Price, 2018 .

The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome

B. Seltzer, T. McRae, G. Capone, 2009, American journal of medical genetics. Part A.

Feeding induction in children who refuse to eat.

B. Handen, D. C. Russo, F. Mandell, 1986, American journal of diseases of children.

Psychostimulant Treatment of Adults With Mental Retardation and Attention-Deficit Hyperactivity Disorder

A. Hardan, R. Jou, B. Handen, 2004 .

Quetiapine in children and adolescents with subaverage IQ

A. Hardan, R. Jou, B. Handen, 2005, Journal of Pediatric Neurology.

Methylphenidate and Play Skills in Children with Intellectual Disability and ADHD

B. Handen, A. E. Sagady, Sarah McAuliffe-Bellin, 2008 .

Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders

A. Hardan, R. Jou, B. Handen, 2005, Journal of autism and developmental disorders.

Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders.

A. Hardan, R. Jou, B. Handen, 2005, Journal of child and adolescent psychopharmacology.

Autism spectrum disorder

J. McGonigle, B. Handen, M. Lubetsky, 2011 .

Verbal Ability and Psychiatric Symptoms in Clinically Referred Inpatient and Outpatient Youth with ASD

S. Santangelo, C. Mazefsky, L. Hagopian, 2017, Journal of Autism and Developmental Disorders.

Affective disorders in hospitalized children and adolescents with mental retardation: a retrospective study.

B. Handen, K. Sacco, M. Lubetsky, 1995, Research in developmental disabilities.

The Autism Impact Measure (AIM): Initial Development of a New Tool for Treatment Outcome Measurement

Z. Warren, M. Mazurek, J. Bellando, 2013, Journal of Autism and Developmental Disorders.

Weight Loss and Alzheimer's Disease in Down Syndrome.

H. D. Rosas, C. Laymon, B. Ances, 2022, Journal of Alzheimer's disease : JAD.

A Prospective Study of the Concordance of DSM-IV and DSM-5 Diagnostic Criteria for Autism Spectrum Disorder

M. Mazurek, R. Hundley, S. Kanne, 2017, Journal of Autism and Developmental Disorders.

A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder.

A. Hardan, B. Handen, 2002, Journal of child and adolescent psychopharmacology.

Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.

Tristram H. Smith, J. Hellings, X. Pan, 2017, Journal of child and adolescent psychopharmacology.

The Impact of the Comorbidity of ASD and ADHD on Social Impairment

M. Mazurek, B. Handen, Christina M. Harkins, 2021, Journal of Autism and Developmental Disorders.

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

B. Leventhal, C. Lord, W. McMahon, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Problem Behaviors in Autism Spectrum Disorder: Association with Verbal Ability and Adapting/Coping Skills

S. Santangelo, C. Mazefsky, Diane L. Williams, 2017, Journal of Autism and Developmental Disorders.

Parent–child interaction therapy (PCIT) in young children with autism spectrum disorder

B. Handen, Ashley T. Scudder, C. Wong, 2019, Child & Family Behavior Therapy.

Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder.

E. Anagnostou, J. Veenstra-VanderWeele, James Chan, 2019, Journal of child and adolescent psychopharmacology.

Dr. Handen et al. Reply.

E. Anagnostou, J. Veenstra-VanderWeele, B. Handen, 2018, Journal of the American Academy of Child and Adolescent Psychiatry.

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2016, JAMA psychiatry.

Age at First Autism Spectrum Disorder Diagnosis: The Role of Birth Cohort, Demographic Factors, and Clinical Features

Lisa Nowinski, Eric Butter, Christopher R. Engelhardt, 2014, Journal of developmental and behavioral pediatrics : JDBP.

Antiepileptic Drugs in Intellectual Disability and/or Autism

B. Handen, M. McCarthy, 2008 .

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome

W. Klunk, B. Christian, N. Schupf, 2020, Alzheimer's & dementia.

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome

C. Laymon, W. Klunk, C. Mathis, 2021, NeuroImage.

Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder

G. Dawson, E. Cook, B. King, 2015, Autism : the international journal of research and practice.

Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders

W. Roberts, E. Anagnostou, A. Hardan, 2012, Pediatrics.

Risk Factors for Self-injurious Behavior in an Inpatient Psychiatric Sample of Children with Autism Spectrum Disorder: A Naturalistic Observation Study

C. Mazefsky, M. Siegel, B. Handen, 2018, Journal of autism and developmental disorders.

Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder

C. McDougle, H. Tager-Flusberg, S. Santangelo, 2017, Journal of Autism and Developmental Disorders.

Risk Factors for Self-injurious Behavior in an Inpatient Psychiatric Sample of Children with Autism Spectrum Disorder: A Naturalistic Observation Study

C. McDougle, H. Tager-Flusberg, S. Santangelo, 2018, Journal of Autism and Developmental Disorders.

Talking About Death or Suicide: Prevalence and Clinical Correlates in Youth with Autism Spectrum Disorder in the Psychiatric Inpatient Setting

S. Santangelo, C. Mazefsky, L. Hagopian, 2017, Journal of Autism and Developmental Disorders.

Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B

W. Klunk, C. Mathis, J. Price, 2012, Alzheimer's & Dementia.

Predictors of Inpatient Psychiatric Hospitalization for Children and Adolescents with Autism Spectrum Disorder

S. Santangelo, C. Mazefsky, Diane L. Williams, 2017, Journal of Autism and Developmental Disorders.

Nutrient Intake From Food in Children With Autism

T. Clemons, S. J. James, A. Reynolds, 2012, Pediatrics.

Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity Disorder

B. Handen, M. Lubetsky, C. Johnson, 2000, Journal of autism and developmental disorders.

Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders.

A. Hardan, B. Handen, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

H. Feldman, J. Janosky, B. Handen, 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

Leisure activity in middle-aged adults with Down syndrome: Initiators, social partners, settings and barriers.

B. Christian, B. Handen, S. Hartley, 2020, Journal of applied research in intellectual disabilities : JARID.

Leisure Activity and Caregiver Involvement in Middle-Aged and Older Adults With Down Syndrome.

Sterling C. Johnson, Patrick J. Lao, B. Christian, 2017, Intellectual and developmental disabilities.

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome

A. Brickman, B. Ances, N. Schupf, 2022, Disability and Health Journal.

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2013, Journal of Autism and Developmental Disorders.

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.

C. McDougle, J. McCracken, L. Scahill, 2014, Child and adolescent psychiatric clinics of North America.

White matter microstructure associations to amyloid burden in adults with Down syndrome

Sterling C. Johnson, Matthew D. Zammit, Patrick J. Lao, 2021, NeuroImage: Clinical.

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study

A. Alexander, C. Laymon, W. Klunk, 2021, Journal of neurodevelopmental disorders.

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation

Sterling C. Johnson, Patrick J. Lao, W. Klunk, 2018, Brain Imaging and Behavior.

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies

C. McDougle, D. Posey, L. Ritz, 2013, Translational Psychiatry.

Acute Regression in Down Syndrome

D. Minhas, C. Laymon, S. O'Bryant, 2021, Brain sciences.

The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

H. D. Rosas, W. Klunk, B. Ances, 2020, Alzheimer's & dementia.

Methylphenidate in children with seizures and attention-deficit disorder.

H. Feldman, P. Crumrine, B. Handen, 1989, American journal of diseases of children.

Pharmacotherapy in Autism and Related Disorders.

B. Handen, M. Lubetsky, 2005 .

Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.

J. Varni, R. Mcquade, R. Mankoski, 2012, Clinical therapeutics.

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

W. Silverman, E. Head, J. Fortea, 2019, Journal of Neurodevelopmental Disorders.

Title Assessing general cognitive and adaptive abilities in adults with Down syndrome : a systematic review

W. Silverman, E. Head, J. Fortea, 2019 .

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Parent training for toileting in autism spectrum disorder.

Tristram H. Smith, R. Foxx, B. Handen, 2019, Parent training for autism spectrum disorder: Improving the quality of life for children and their families..

Behavioral Aspects of Disorders of Defecation and Fecal Continence

B. Handen, A. Wald, 1987 .

Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.

Luc Lecavalier, Karen Bearss, Eric Butter, 2015, JAMA.

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.

C. McDougle, L. Ritz, L. Scahill, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Neuropathological correlates of amyloid PET imaging in Down syndrome

W. Klunk, B. Christian, E. Mufson, 2019, Developmental neurobiology.

Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease

V. Villemagne, E. Head, M. Ikonomovic, 2021, Frontiers in Aging Neuroscience.

Comparison of longitudinal Aβ in nondemented elderly and Down syndrome

Sterling C. Johnson, Charles M. Laymon, Ann D. Cohen, 2019, Neurobiology of Aging.

Long-Term Follow-Up of Children with Mental Retardation/Borderline Intellectual Functioning and ADHD

J. Janosky, B. Handen, S. McAuliffe, 1997, Journal of abnormal child psychology.

Four-year follow-up of children with low intelligence and ADHD.

J. Rojahn, B. Handen, M. Aman, 1996, Research in developmental disabilities.

Effects and noneffects of methylphenidate in children with mental retardation and ADHD.

H. Feldman, J. Janosky, B. Handen, 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder

C. McDougle, B. Handen, J. Bruss, 2009, Journal of autism and developmental disorders.

A Pilot Study of Parent Training in Young Children with Autism Spectrum Disorders and Disruptive Behavior

Tristram H. Smith, L. Scahill, B. Handen, 2012, Journal of Autism and Developmental Disorders.

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

C. McDougle, L. Ritz, L. Scahill, 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy of Methylphenidate and Behavioral Intervention on Classroom Behavior in Children with ADHD and Mental Retardation

B. Handen, K. Sacco, M. Lubetsky, 1994, Behavior modification.

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome

Sterling C. Johnson, Matthew D. Zammit, M. Sabbagh, 2021, NeuroImage: Clinical.

A Prospective Study of the Concordance of DSM-IV and DSM-5 Diagnostic Criteria for Autism Spectrum Disorder

Micah O. Mazurek, M. Mazurek, H. Symecko, 2017, Journal of Autism and Developmental Disorders.

A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges.

Tristram H. Smith, Xiaobai Li, X. Pan, 2014, Research in autism spectrum disorders.

Naltrexone in young autistic children: replication study and learning measures.

H. Feldman, J. Janosky, B. Handen, 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

Selective Serotonin Reuptake Inhibitor Monotherapy for Anxiety Disorders in Children and Adolescents with Autism Spectrum Disorder: A Chart Review.

B. Handen, Gregory Thorkelson, Kylan S. Turner, 2019, Journal of child and adolescent psychopharmacology.

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.

Tristram H. Smith, C. McDougle, B. King, 2019, Comprehensive psychiatry.

Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems

C. McDougle, L. Scahill, C. Farmer, 2011, Journal of Autism and Developmental Disorders.

Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems

C. McDougle, L. Scahill, C. Farmer, 2011, Journal of Autism and Developmental Disorders.

Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials

C. McDougle, L. Scahill, E. Butter, 2009, Journal of intellectual & developmental disability.

Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder

C. McDougle, L. Scahill, L. E. Arnold, 2018 .

The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods

Bradley T. Christian, Charles M. Laymon, Ann D. Cohen, 2018, Alzheimer's & dementia.

Prevention Strategies

Tristram H. Smith, L. Scahill, E. Butter, 2018, Parent Training for Disruptive Behavior.

Preschoolers with Developmental Disabilities: A Comparison of an ADHD and a NonADHD Group

B. Handen, Lourdes Valdes, 2007 .

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

H. Feldman, B. Handen, P. Murray, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

Polyunsaturated Fatty Acid Supplementation in Young Children with Autism

B. Handen, K. Sacco, C. Johnson, 2010 .

The Collaborative Team as a Training and Therapeutic Tool

B. Handen, Dusty Miller, M. Sperling, 1986 .

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

A. Fagan, H. D. Rosas, J. Chhatwal, 2021, The Lancet Neurology.

CSF Biomarkers in Down Syndrome and Autosomal Dominant Alzheimer Disease

A. Fagan, H. D. Rosas, J. Chhatwal, 2021 .

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2014, Journal of autism and developmental disorders.

Teaching symbol identification: A comparison between standard prompting and intervening response procedures

B. Handen, T. Zane, S. A. Mason, 1984 .

A comparison of the stimulus delay procedure and simultaneous stimulus presentation.

B. Handen, 1981 .

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder

Johanna Taylor, B. Handen, R. Tumuluru, 2011, International journal of adolescent medicine and health.

Stimulant medication effects on learning in children with mental retardation and ADHD

B. Handen, Lourdes M. Caro-Martinez, S. McAuliffe, 1996 .

Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder.

A. Hardan, R. Jou, B. Handen, 2004, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use

E. Anagnostou, J. Veenstra-VanderWeele, L. E. Arnold, 2018, Journal of child and adolescent psychopharmacology.

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Sterling C. Johnson, John X. Morris, Omar H. Butt, 2023, The Lancet Neurology.

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome

A. Fagan, W. Klunk, B. Christian, 2020, Alzheimer's & dementia.

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

A. Granholm, J. Santoro, A. Rebillat, 2022, Molecular Syndromology.

Sleep and White Matter in Adults with Down Syndrome

A. Alexander, D. Plante, B. Handen, 2021, Brain sciences.

Stress and Stress Management with the Elderly

B. Handen, 1991 .

Comparison of Parent and Teacher Assessments of Developmentally Delayed Children's Behavior

R. Feldman, B. Handen, B L Handen, 1987, Exceptional children.

Testing Genetic Modifiers of Behavior and Response to Atomoxetine in Autism Spectrum Disorder with ADHD

Tristram H. Smith, W. Sadee, G. Herman, 2018, Journal of Developmental and Physical Disabilities.

Testing Genetic Modifiers of Behavior and Response to Atomoxetine in Autism Spectrum Disorder with ADHD

Tristram H. Smith, W. Sadee, G. Herman, 2018, Journal of developmental and physical disabilities.

Leisure Activity, Brain β‐amyloid, and Episodic Memory in Adults with Down Syndrome

Patrick J. Lao, W. Klunk, O. Okonkwo, 2019, Developmental neurobiology.

Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, S. White, L. Scahill, 2013, Journal of developmental and physical disabilities.

Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, S. White, L. Scahill, 2012, Journal of Developmental and Physical Disabilities.

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report

Young T. Hong, W. Klunk, D. Menon, 2019, Alzheimer's & dementia.

Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders.

Tristram H. Smith, L. Scahill, E. Butter, 2013, Neuropsychiatry.

Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, L. Ritz, J. McCracken, 2009, Journal of autism and developmental disorders.

The Influence of Social Support Factors on the Well-Being of the Elderly

B. Handen, 1991 .

The Autism Impact Measure (AIM): Initial Development of a New Tool for Treatment Outcome Measurement

Micah O. Mazurek, Z. Warren, M. Mazurek, 2013, Journal of Autism and Developmental Disorders.

Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'

A. Reiersen, B. Handen, 2011, Evidence-based child health : a Cochrane review journal.

Plasma NT1-tau and AÎ²42 correlate with age and cognitive function in two large Down syndrome cohorts

D. Selkoe, S. O'Bryant, M. Mapstone, 2023, medRxiv.

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation

Patrick J. Lao, W. Klunk, J. Price, 2018, Brain Imaging and Behavior.

PET imaging in Down syndrome and Alzheimer's disease

B. Handen, B. Christian, 2022, The Neurobiology of Aging and Alzheimer Disease in Down Syndrome.

Prevalence of Comorbidities in Middle-Aged and Older Adults Diagnosed with Autism Spectrum Disorder: A De-Identified Retrospective Review of Medical Records with Peer-Matched Comparison & Qualitative Review of Barriers Associated with Autism spectrum disorders in Adults

S. Albert, B. Handen, Cary Lee Zik, 2022 .

Development of a parent training program for children with pervasive developmental disorders

Susan K. Williams, Tristram H. Smith, C. McDougle, 2007 .

A Playroom Observation Procedure to Assess Children with Mental Retardation and ADHD

H. Feldman, J. Janosky, B. Handen, 1998, Journal of abnormal child psychology.

Methylphenidate in children with mental retardation and ADHD: Effects on independent play and academic functioning

H. Feldman, J. Janosky, B. Handen, 1995 .

A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders.

A. Hardan, R. Jou, B. Handen, 2004, Journal of child and adolescent psychopharmacology.

Using guided compliance versus time out to promote child compliance: a preliminary comparative analysis in an analogue context.

B. Handen, J. Parrish, M. E. Kerwin, 1992, Research in developmental disabilities.

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Patricia J. Murray, A. Hardan, B. Handen, 2011, Journal of child and adolescent psychopharmacology.

The effect of social support and stress on the health of community-living elderly.

B. Handen, 1985 .

Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder

Tristram H. Smith, X. Pan, L. E. Arnold, 2018, Journal of autism and developmental disorders.

Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder

Tristram H. Smith, X. Pan, L. E. Arnold, 2017, Journal of Autism and Developmental Disorders.

A Pilot Study of Parent Training in Young Children with Autism Spectrum Disorders and Disruptive Behavior

Tristram H. Smith, L. Scahill, B. Handen, 2012, Journal of Autism and Developmental Disorders.

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study

Young T. Hong, W. Klunk, T. Fryer, 2022, Alzheimer's & dementia.

Early Childhood Interventions

J. McGonigle, B. Handen, M. Lubetsky, 2011 .

Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts.

D. Selkoe, S. O'Bryant, M. Mapstone, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

The Worry Scale as a measure of anxiety among homebound and community active elderly.

B. Handen, C. Morse, P. Wisocki, 1986 .

Factors associated with DSM-5 severity level ratings for autism spectrum disorder

Micah O. Mazurek, M. Mazurek, B. Handen, 2019, Autism : the international journal of research and practice.

The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder

J. Bregman, A. Kolevzon, N. Minshew, 2019, Journal of Autism and Developmental Disorders.

Behavioral Symptoms of Reported Abuse in Children and Adolescents with Autism Spectrum Disorder in Inpatient Settings

S. Santangelo, C. Mazefsky, Diane L. Williams, 2017, Journal of Autism and Developmental Disorders.

Role of tau deposition in early cognitive decline in Down syndrome

Matthew D. Zammit, C. Laymon, B. Ances, 2022, Alzheimer's & dementia.

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome

N. Schupf, W. Silverman, M. Pulsifer, 2022, Alzheimer's & dementia.

Effects of Gluten Free / Casein Free Diet in Young Children with Autism: A Pilot Study

B. Handen, K. Sacco, C. Johnson, 2011 .

Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.

C. McDougle, Xiaobai Li, L. Scahill, 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

Primary caregiver education level and sleep problems in children with autism spectrum disorder

Sowmya R. Rao, B. Handen, Miya R. Asato, 2020, Journal of sleep research.

Characterizing the emergence of amyloid and tau burden in Down syndrome.

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.

Matthew D. Zammit, Jamie C. Peven, D. Minhas, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Comparison of amyloid accumulation between Down syndrome and autosomal‐dominant Alzheimer disease

Nick C Fox, Omar H. Butt, A. Fagan, 2022, Alzheimer's & Dementia.

Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome

C. Laymon, B. Ances, O. Okonkwo, 2021, Neurobiology of Aging.

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

W. Silverman, E. Head, J. Fortea, 2019, Journal of Neurodevelopmental Disorders.

Summary of Lessons Learned from Two Studies: An Open Clinical Trial and a Randomized Controlled Trial of PCIT and Young Children with Autism Spectrum Disorders

B. Handen, Ashley T. Scudder, Marissa Mendoza-Burcham, 2018 .

Secretin in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled Trial

B. Handen, D. Hofkosh, 2005 .

Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.

Jamie C. Peven, D. Minhas, C. Laymon, 2023, Journal of Alzheimer's disease : JAD.

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease

J. Hassenstab, A. Rebillat, E. Head, 2021, Alzheimer's & dementia.

The Home Situations Questionnaire-PDD version: factor structure and psychometric properties.

C. McDougle, L. Scahill, D. Sukhodolsky, 2010, Journal of intellectual disability research : JIDR.

RUPP AUTISM NETWORK RANDOMIZED CLINICAL TRIAL OF PARENT TRAINING AND MEDICATION: ONE-YEAR FOLLOW-UP

Xiaobai Li, L. Scahill, E. Butter, 2013 .

Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome

Sterling C. Johnson, Regina M. Hardison, Patrick J. Lao, 2017, Neurobiology of Aging.

Association of Sleep with Cognition and β -Amyloid Accumulation in Adults with Down Syndrome

Matthew D. Zammit, W. Klunk, K. Cody, 2020 .

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Nutrient Intake From Food in Children With Autism

T. Clemons, A. Reynolds, C. Molloy, 2012, Pediatrics.

Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials

C. McDougle, L. Scahill, E. Butter, 2009, Journal of intellectual & developmental disability.

The Search for Biomarkers of Alzheimer's Disease in Down Syndrome.

B. Handen, 2020, American journal on intellectual and developmental disabilities.

A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.

Tristram H. Smith, X. Pan, B. Handen, 2018, Journal of child and adolescent psychopharmacology.

Nutrient Intake From Food in Children With Autism abstract The impact of abnormal feeding behaviors reported for

C. Molloy, B. Handen, Brianne Schmidt, 2012 .